Chronic (transformed) migraine and medication overuse: to withdraw or not?

References

• Stewart WF, Shechter A, Lipton RB. Migraine heterogeneity, disability, pain intensity, and attack frequency and duration. Neurology44(Suppl. 4), S24–S39 (1994).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ. Pathophysiology of migraine. In: Wolff’s Headache and Other Head Pain (7th Edition). Silberstein SD, Lipton RB, Dalessaio DJ (Eds). Oxford University Press, Oxford, UK 57–72 (2001).
   Google Scholar
• May A, Goadsby PJ. The trigeminovascular system in humans: pathophysiology implications for primary headache syndromes of the neural influences on the cerebral circulation. J. Cereb. Blood Flow Metab.19, 115–127 (1999).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Lipton RB, Ferrari MD. Migraine – current understanding and treatment. N. Engl. J. Med.346, 257–270 (2002).
   PubMed Web of Science ®Google Scholar
• Welch KMA, Barkley GL, Tepley N et al. Central neurogenic mechanisms of migraine. Neurology43, S21–S25 (1993).
   Web of Science ®Google Scholar
• Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headache: a filed study of revised IHS criteria. Neurology47, 871–875 (1996).
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders (2nd Edition). Cephalalgia24(Suppl. 1), 1–160 (2004).
   Web of Science ®Google Scholar
• Scholz E, Diener HC, Geiselhart S, Wilkinson M. Drug-induced headache – does a critical dose exist? In: Drug-induced Headache. Diener HC (Ed.). Springer-Verlag, Berlin, Germany 29–43 (1988).
   Google Scholar
• Zwart JA, Dyb G, Hagen K, Svebak S, Holmen J. Analgesic use: a predictor of chronic pain and medication overuse headache. Neurology61, 160–164 (2003).
   PubMed Web of Science ®Google Scholar
• Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC. Features of medication overuse headache following overuse of different acute headache drugs. Neurology59, 1011–1014 (2002).
   PubMed Web of Science ®Google Scholar
• Dodick DW, Freitag F. Evidence-based understanding of medication-overused headache: clinical implications. Headache46(Suppl. 4), S202–S211 (2006).
   Google Scholar
• Diener HC, Katsarava Z. Medication overuse headache. Curr. Med. Res. Opin.17, 17–21 (2002).
   Google Scholar
• Grazzi L, Andrasic F, D’Amico D, Usai S, Kass S, Bussone G. Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow up. Headache44, 678–683 (2004).
   PubMedGoogle Scholar
• Relja G, Granato A, Bratina A, Antonello RM, Zorzon M. Outcome of medication overuse headache after abrupt in-patient withdrawal. Cephalalgia26, 589–595 (2006).
   PubMedGoogle Scholar
• Krymchantowski AV, Moreira PF. Out-patient detoxification in chronic migraine: comparison of strategies. Cephalalgia23, 982–993 (2003).
   PubMedGoogle Scholar
• Dodick D. Personal communication. Presented at: XX Brazilian Headache Congress. Belo Horizonte, Minas Gerais, Brazil, 14–19 September 2006.
   Google Scholar
• Diener HC. Personal communication. Presented at: 49th Annual Scientific Meeting of the American Headache Society. Clinical Crossfire Session. Chicago, IL, USA, 6–10 June 2007.
   Google Scholar
• Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ. On behalf of the TOPMAT-MIG-201(TOP-CHROME) Study Group. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia (2007) (In Press).
   Google Scholar
• Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia26, 1097–1105 (2006).
   PubMed Web of Science ®Google Scholar
• Breslau N, Merikangas K, Bowden CL. Comorbidity of migraine and major affective disorders. Neurology44, S17–S22 (1994).
   PubMed Web of Science ®Google Scholar
• Merikangas K, Stevens DE. Comorbidity of migraine and psychiatric disorders. In: Neurologic Clinics: Advances in Headache. Mathew NT (Ed.). Saunders, PA, USA 115–124 (1997).
   Google Scholar
• Saper J. Borderline personality disorder and the chronic headache patient: review and management recommendations. Headache42, 663–674 (2002).
   PubMed Web of Science ®Google Scholar
• Mathew NT. Medication misuse headache. Cephalalgia18(Suppl. 21), 34–36 (1998).
   PubMedGoogle Scholar
• Srikiatkhachorn A, Puanguiyon MS, Govitrapong P. Plasticity of 5-HT serotonin receptor in patients with analgesic-induced transformed migraine. Headache38, 534–539 (1998).
   PubMedGoogle Scholar
• Welch KM, Nagesh V, Aurora S, Gelman N. Periaqueductal gray matter disfunction in migraine: cause or the burden of illness. Headache41, 629–637 (2001).
   PubMed Web of Science ®Google Scholar
• Mao J. Opioid-induce abnormal pain sensitivity: implications in clinical practice. Pain100, 213–217 (2002).
   PubMed Web of Science ®Google Scholar
• Meng ID, Porreca F. Basic science: mechanisms of medication overuse. Headache Curr.1, 47–54 (2004).
   Google Scholar
• Guidetti V, Galli F, Fabrizi P et al. Headache and psychiatric co-morbidity: clinical aspects and outcome in a 8-year follow-up study. Cephalalgia18, 455–462 (1998).
   PubMed Web of Science ®Google Scholar
• Linehan MM. Combining pharmacotherapy with psychotherapy for substance abusers with borderline personality disorder: strategies for enhancing compliance. NIDA Res. Monogr.150, 129–142 (1995).
   PubMedGoogle Scholar
• Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology57, 1694–1698 (2001).
   PubMed Web of Science ®Google Scholar
• Saper J, Lake AE III, Hamel RL et al. Daily scheduled opioids for intractable head pain: long-term observations of a treatment program. Neurology62, 1687–1694 (2004).
   PubMedGoogle Scholar
• Lake AE III, Saper J, Hamel RL. Inpatient treatment of intractable headache: outcome for 267 consecutive program completers. Headache46, 893 (2006) (Abstract).
   Google Scholar